Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of rosiglitazone on bone turnover and bone marrow cells
2007-004714-14Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of rosiglitazone in osteoporosis, sponsored by Aarhus University Hospital. Primary endpoint: Bone loss by DXA scans after 14 weeks of rosiglitazone. Started Sep 2007; status: completed.
02
Drugs
rosiglitazone
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2007-004714-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004714-14.